Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Farmabios S.p.A. | Gropello Cairoli, Italy | Makes the active ingredient | Problems found, fixed voluntarilyOct 1, 2021 · 6 inspections |
Recalls
- Aug 22, 2022 · Class II · Cipla
Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.
Lots: Lot # DEG5BD2, Exp 07/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Difluprednate: every company that makes it
- Form
- emulsion
- Strength
- 0.5 mg per 1 mL
- Approval
- ANDA ANDA211776
- On the market since
- Dec 10, 2021
- Package NDCs
76282-708-50- Official label
- DailyMed (National Library of Medicine), updated Dec 10, 2021
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?